HWA
Hillcrest Wealth Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Sell |
19,413
-2,260
| -10% | -$187K | 0.76% | 22 |
|
|
2025
Q1 | $1.76M | Buy |
21,673
+7,310
| +51% | +$593K | 0.87% | 22 |
|
|
2024
Q4 | $1.29M | Buy |
14,363
+7,245
| +102% | +$652K | 0.61% | 25 |
|
|
2024
Q3 | $703K | Sell |
7,118
-1,200
| -14% | -$119K | 0.35% | 27 |
|
|
2024
Q2 | $771K | Sell |
8,318
-975
| -10% | -$90.4K | 0.42% | 26 |
|
|
2024
Q1 | $882K | Sell |
9,293
-255
| -3% | -$24.2K | 0.48% | 25 |
|
|
2023
Q4 | $853K | Sell |
9,548
-13,725
| -59% | -$1.23M | 0.47% | 27 |
|
|
2023
Q3 | $1.7M | Buy |
23,273
+5,605
| +32% | +$409K | 0.97% | 23 |
|
|
2023
Q2 | $1.47M | Sell |
17,668
-3,700
| -17% | -$308K | 0.87% | 25 |
|
|
2023
Q1 | $1.63M | Buy |
21,368
+125
| +0.6% | +$9.53K | 0.97% | 26 |
|
|
2022
Q4 | $1.76M | Buy |
21,243
+480
| +2% | +$39.8K | 1.05% | 24 |
|
|
2022
Q3 | $1.65M | Sell |
20,763
-5,710
| -22% | -$453K | 1.04% | 26 |
|
|
2022
Q2 | $1.97M | Buy |
26,473
+990
| +4% | +$73.5K | 1.19% | 22 |
|
|
2022
Q1 | $2.29M | Buy |
25,483
+6,760
| +36% | +$607K | 1.27% | 22 |
|
|
2021
Q4 | $2.1M | Buy |
18,723
+10,695
| +133% | +$1.2M | 1.13% | 22 |
|
|
2021
Q3 | $1.01M | Buy |
8,028
+2,853
| +55% | +$359K | 0.6% | 26 |
|
|
2021
Q2 | $701K | Sell |
5,175
-9,240
| -64% | -$1.25M | 0.42% | 28 |
|
|
2021
Q1 | $1.96M | Buy |
14,415
+12,365
| +603% | +$1.68M | 1.19% | 22 |
|
|
2020
Q4 | $289K | Sell |
2,050
-900
| -31% | -$127K | 0.19% | 43 |
|
|
2020
Q3 | $329K | Buy |
+2,950
| New | +$329K | 0.23% | 46 |
|
|
2019
Q4 | – | Sell |
-4,400
| Closed | -$336K | – | 41 |
|
|
2019
Q3 | $336K | Hold |
4,400
| – | – | 0.29% | 33 |
|
|
2019
Q2 | $386K | Buy |
4,400
+1,200
| +38% | +$105K | 0.33% | 33 |
|
|
2019
Q1 | $290K | Buy |
3,200
+400
| +14% | +$36.3K | 0.25% | 34 |
|
|
2018
Q4 | $201K | Buy |
+2,800
| New | +$201K | 0.19% | 41 |
|